Stroke of luck: Scientists discover target for stroke therapy in blood-brain barrier
New study shows that stroke byproduct acrolein activates the precursor of heparanase, an enzyme that degrades the glycocalyx in the ...
New study shows that stroke byproduct acrolein activates the precursor of heparanase, an enzyme that degrades the glycocalyx in the ...
The @Oncotarget authors show a drug class-effect with MEKi to stimulate NK cells, inhibit inflammatory cytokines and block host-factors for ...
"The results suggest that this product, or similar fusion proteins featuring an N-terminal fusion in the diabody format, may deserve ...
"The @Oncotarget authors demonstrate that MEK inhibitors are a promising targeted therapy for the basal subtype of bladder cancer, and ...
New technology will help researchers predict the outcomes of drug efficacy and can guide the development of drug treatments for ...
New research suggests that more than 100 chemicals found in plastic toy materials may pose possible health risks to children.Credit: ...
Credit: IRB Barcelona The systemic balance that coordinates the growth of an organism and its progress through the different stages ...
Credit: Oregon State University CORVALLIS, Ore. - Oregon State University and U.S. Department of Agriculture researchers have significantly expanded the ...
Credit: George Sflomos (EPFL) Invasive lobular carcinoma (ILC) is a type of breast cancer that begins in the milk-producing glands ...
The molecule, interleukin-33, activates signals in a cell's nucleus to promote abnormal growth.Credit: Jong Ho Park, PhD BOSTON - Chronic ...
Credit: Karolinska Institutet. Disorders of the cells' energy supply can cause a number of serious diseases, but also seem to ...
Credit: UHN StRIDe Team Creating "super soldiers" of specific white blood cells to boost an anti-tumour response has been shown ...
Study results could lead to more effective treatment options for GIST patients, which are currently limitedCredit: UC San Diego Health ...
Chemotherapy-sparing regimen meets primary endpoint in Phase II studyCredit: MD Anderson Cancer Center HOUSTON -- The first randomized Phase II ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.